Introduction
Dihydroberberine (see Scheme 1, parts a and b) is a reduced form of berberine (see Scheme 1, part c), an isoquinoline alkaloid isolated from shrubs of the genus berberis. It is a very important pharmacological compound with a diverse range of biological activities (Amin et al., 1969; Akhter et al., 1979; Swabb et al., 1981; Sack & Froehlich, 1982; Sun et al., 1988; Yuan et al., 1994; Birdsall & Kelly, 1997; Gibbs & Seddon, 2000) . With a change of only one degree of unsaturation in its chemical structure, dihydroberberine does not show diminished biological activity but rather exhibits improved results in some cases. Due to its enhanced bioavailability, dihydroberberine improves in vivo efficacy in terms of counteracting increased adiposity and insulin resistance in high-fat rodents (Turner et al., 2008) . It has also been found to be effective in site-specific sustained release of drugs to the brain by under-going in vivo transformation into berberine (Bodor et al., 1981; . Further derivatization of dihydroberberine by the introduction of hydroxy and cyano groups onto the reduced ring leads to active antimalarials (Vennerstrom & Klayman, 1988) , avian myeblastosis virus inhibitors (AMV-RT) (Kusumoto et al., 1991) , antitumour agents (Kim et al., 1997) , antifungals (Dostá l et al., 1999) , mitogen-activated protein kinase inhibitors (MAPKK) (Jang et al., 2002) , promoters of glucose metabolism and insulin secretion (Xu et al., 2011) , and CD36 antagonists (Li et al., 2010) . Dihydroberberine has found use as an intermediate in the synthesis of substituted berberine analogues which were found to act as anticancer agents (Zhang et al., 2012) , pancreatic lipase inhibitory agents (Mohammad et al., 2013) , antifungal agents (Li et al., 2013) , Toxoplasma gondii inhibitors (Krivogorsky et al., 2012) , and mitochondria-targeted antioxidants (Lyamzaev et al., 2011) , and which have shown activity as antibabesial (Subeki et al., 2005) and antileishmania agents (Marquis et al., 2003) and as HIV-1 RT inhibitors (Vennerstrom et al., 1990) .
With such varied and important biological activity obtained through a minor change in the unsaturation of the compound, we were motivated to characterize dihydroberberine structurally by X-ray crystallography. Surprisingly, while the structure of berberine crystallized with a variety of counter-anions has been reported (Moniot & Shamma, 1979; Abadi et al., 1984; Kariuki & Jones, 1995; Marek, Sečká řová et al., 2003; Tong et al., 2010; Chahine et al., 2011) , as have the structures of an assortment of 8-substituted derivatives of dihydroberberine (Man et al., 2001; Dostá l et al., 2004; Maier et al., 2010; Man et al., 2011) , a determination of the crystal structure of dihydroberberine itself has not been undertaken. Herein, we report its crystal structure from X-ray diffraction data at 150 K.
Experimental

Synthesis and crystallization
To a stirred solution of berberine chloride (3.71 g, 10 mmol) and K 2 CO 3 (3.6 g, 30 mmol) in MeOH (125 ml), a 5% NaOH solution (5 ml) containing NaBH 4 (0.3 g, 7.5 mmol) was added dropwise. The reaction mixture was stirred at room temperature for 1 h, and the precipitated product was filtered and washed with 30% EtOH (20 ml) followed by 80% EtOH (20 ml). It was then recrystallized from absolute EtOH (400 ml) to afford 2.8 g (83%) of (I) as green-brown needles. MS, m/z: 340. 1 H NMR (CDCl 3 ): 7.19 (s, 1H), 6.76 (s, 2H), 6.59 (s, 1H), 5.97 (s, 1H), 5.96 (s, 2H), 4.34 (s, 2H), 3.86 (s, 6H), 3.15 (t, 2H), 2.89 (t, 2H).
Refinement
Crystal data, data collection and structure refinement details are summarized in Table 1 . H atoms were identified in the final difference map, and their positions were refined along with their isotropic displacement parameters that were approximately 1.2-1.5 times the equivalent displacement parameters of the C atoms to which they were attached. Rigidbond restraints were applied to the atomic displacement parameters of bonded atoms and 1,3-distances for all non-H atoms.
Results and discussion
The structure of dihydroberberine ( Fig. 1 ) is derived from berberine by reduction of the N7-C8 bond. The partial saturation of the quinolizine ring system at the C5-C6 and N7-C8 positions induces a bending of the fused-ring system (see Fig. 1 and part b of Scheme 1), with the fully unsaturated arene rings at the ends of the molecule disposed at a dihedral angle of 27.94 (5) . The corresponding angle in berberine is approximately 12.4 (3) (Kariuki & Jones, 1995) , owing to the unsaturation at the N7-C8 bond. Atoms C6 and C8 are both folded up towards the top side of the dihydroquinolizine ring system, as presented in the figure, such that the dihedral angle between the C5/C4a/C13b/C13a/N7 and C5/C6/N7 mean planes is 48.0 (1) , and that between the N7/C13a/C13/C12a/ C8a and N7/C8/C8a mean planes is 41.47 (9) . The tertiary N atom is slightly pyramidal, displaced by 0.315 (1) Å from the plane of the three surrounding C atoms. As such, it constitutes a chiral center. The molecule depicted in Fig. 1 shows the S configuration; the opposite enantiomer necessarily occurs in the unit cell as well, related by an inversion center to the molecule shown, as the space group is centric. Importantly, the unit-cell packing arrangement for dihydroberberine occurs as two-dimensional sheets, the formation of which is governed by a network of hydrogen bonds, despite the absence of a typical O-H or N-H donor in the molecule. Here, the acetal-type -CH 2 -group of the 1,3dioxole ring is sufficiently activated by the geminal O atoms that both of its H atoms function as hydrogen-bond donors. One pair of hydrogen-bond interactions occurs between this -CH 2 -group and the tertiary amine N atom of a neighbouring Computer programs: APEX2 (Bruker, 2010) , SAINT (Bruker, 2009 ), SHELXS97 (Sheldrick, 2008) , SHELXL97 (Sheldrick, 2008) and SHELXTL (Sheldrick, 2008) .
Figure 1
The molecular structure of dihydroberberine, showing the atomnumbering scheme. Displacement ellipsoids are drawn at the 50% probability level. Table 2 Hydrogen-bond geometry (Å , ). (15) 2.407 (15) 3.3031 (15) 156.2 (11) C2-H2BÁ Á ÁN7 ii 0.995 (15) 2.620 (15) 3.5326 (17) 152.5 (11) Symmetry codes: (i) x; Ày þ 3 2 ; z À 1 molecule, the two molecules being disposed about a center of symmetry as a pair of enantiomers. Such pairs of molecules are easily seen (Fig. 2 ) situated along the a edges of the unit cell, the mid-point of which is coincident with the inversion center.
A second set of hydrogen bonds is formed between the other H atom of the acetal-type -CH 2 -group and the methoxy O atom of another molecule further along the c axis and related to the first molecule by a 2 1 screw axis. Each enantiomeric pair of dihydroberberine molecules, typified by the one at the very center of the unit-cell diagram in Fig. 2 , enjoys four hydrogen bonds of this second type, one at each corner of the diad, such that the network is extended above and below in the direction of the b axis.
The donor-acceptor distance in the first type of hydrogen bond noted above (C2Á Á ÁN7 ii ) is 3.5326 (17) Å , and the D-HÁ Á ÁA angle is 152.5 (11) [symmetry code (ii) is as in Table 1 ]. For the second set of hydrogen bonds involving a methoxy O atom as acceptor, the corresponding values are 3.3031 (15) Å and 156.2 (11) . These distances and angles are typical of a 'weak hydrogen bond', as defined by Desiraju & Steiner (1999) . The occurrence of acetal-type C-HÁ Á ÁO hydrogen bonds has been shown to be important in governing the properties of polymethylene glycol and related oligomeric and small molecules. In dimethylene glycol, HOCH 2 OCH 2 OH, two internal hydrogen bonds of this type occur in the energyminimized structure and have been computationally assessed as conferring approximately 2.65 kcal mol À1 (1 kcal mol À1 = 4.184 kJ mol À1 ) of stabilization per hydrogen bond (Martin & Miller, 2009) . Although individually weak as hydrogen bonds, the collective effect of multiple C-HÁ Á ÁX bonds of this type becomes important. It has been assumed that the therapeutic efficacy of berberine arises from a capacity to function as an intercalator into DNA. The foregoing observation of C-HÁ Á ÁX (X = O or N) hydrogen bonds in the crystal packing of dihydroberberine suggests the possibility that analogous hydrogen bonds may exert themselves in the interaction of berberine (and variants thereof) with DNA, in addition to the stacking that occurs upon intercalation.
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9,10-Dimethoxy-6,8-dihydro-5H-1,3-dioxolo[4,5-g]isoquinolino[3,2-a]isoquinoline
Special details
Experimental. The diffraction data were obtained from 3 sets of 400 frames, each of width 0.5° in ω, collected at φ = 0.00, 90.00 and 180.00°, and 2 sets of 800 frames, each of width 0.45° in φ, collected at ω = -30.00 and 210.00°. The scan time was 60 sec/frame. Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes. Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > σ(F 2 ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 ) (7) 0.0236 (6) −0.0033 (5) −0.0011 (4) −0.0004 (5) C6 0.0264 (6) 0.0295 (6) 0.0237 (6) −0.0084 (5) −0.0017 (5) −0.0009 (5) C8 0.0298 (6) 0.0208 (5) 0.0209 (6) −0.0037 (5) −0.0016 (5) 0.0010 (4) C8a 0.0194 (5) 0.0183 (5) 0.0214 (5) 0.0022 (4) −0.0004 (4) 0.0000 (4) C9 0.0199 (5) 0.0174 (5) 0.0222 (5) 0.0015 (4) 0.0014 (4) 0.0024 (4) C10 0.0215 (5) 0.0220 (5) 0.0180 (5) 0.0026 (4) −0.0002 (4) 0.0004 (4) C11 0.0187 (5) 0.0261 (5) 0.0241 (6) −0.0022 (4) −0.0022 (4) −0.0007 (4) C12a 0.0179 (5) 0.0236 (5) 0.0217 (6) 0.0030 (4) 0.0011 (4) 0.0008 (4) C12 0.0185 (5) 0.0292 (6) 0.0238 (6) −0.0024 (4) 0.0018 (4) 0.0036 (4) C13b 0.0220 (5) 0.0189 (5) 0.0196 (5) 0.0024 (4) 0.0004 (4) −0.0021 (4) C13 0.0194 (5) 0.0271 (6) 0.0201 (5) 0.0000 (4) 0.0028 (4) 0.0007 (4) C13a 0.0206 (5) 0.0203 (5) 0.0196 (5) 0.0032 (4) 0.0022 (4) −0.0012 (4) C14 0.0212 (5) 0.0239 (5) 0.0205 (5) 0.0018 (4) 0.0002 (4) −0.0016 (4) C14a 0.0251 (6) 0.0207 (5) 0.0217 (6) 0.0026 (4) 0.0045 (4) −0.0012 (4) C15 0.0261 (6) 0.0363 (7) 0.0332 (7) −0.0043 (5) 0.0073 (5) 0.0021 (6) (17) 
